A device for producing an azo compound includes a reaction unit in which a first solution comprising a hydrazo compound and at least one type of M.sub.aX.sub.b; a negative electrode disposed to be in direct contact with the hydrazo compound inside the reaction unit; and a positive electrode disposed inside the reaction unit so as to be in contact with the solution. X is a halogen element, M is at least one selected from the group consisting of hydrogen, Li, Na, K, Mg, Ca, Mn, Fe, Ni, Cu, Ag, Zn, Sn, Zr, and Ti, or at least one selected from the group consisting of a primary ammonium ion, a secondary ammonium ion, and a tertiary ammonium ion, H is hydrogen, and a and b are each independently any one integer between 1 and 4.

A device for producing an azo compound includes a reaction unit in which a first solution comprising a hydrazo compound and at least one type of M.sub.aX.sub.b; a negative electrode disposed to be in direct contact with the hydrazo compound inside the reaction unit; and a positive electrode disposed inside the reaction unit so as to be in contact with the solution. X is a halogen element, M is at least one selected from the group consisting of hydrogen, Li, Na, K, Mg, Ca, Mn, Fe, Ni, Cu, Ag, Zn, Sn, Zr, and Ti, or at least one selected from the group consisting of a primary ammonium ion, a secondary ammonium ion, and a tertiary ammonium ion, H is hydrogen, and a and b are each independently any one integer between 1 and 4.

A quinone derivative represented by general formula (1) where, in the general formula (1), chemical groups R.sub.1 each represent, independently of one another, an alkyl group, a cycloalkyl group, an alkoxy group, an aralkyl group, or an aryl group, and R.sub.2 represents an alkyl group, an aralkyl group, a cycloalkyl group, an alkoxy group, an aryl group, or a heterocyclic group. ##STR00001##

A quinone derivative represented by general formula (1) where, in the general formula (1), chemical groups R.sub.1 each represent, independently of one another, an alkyl group, a cycloalkyl group, an alkoxy group, an aralkyl group, or an aryl group, and R.sub.2 represents an alkyl group, an aralkyl group, a cycloalkyl group, an alkoxy group, an aryl group, or a heterocyclic group. ##STR00001##

Method of processing and handling solids and mixtures capable of deflagration, in particular of processing materials capable of deflagration in the chemical and pharmaceutical industry, wherein the processing and handling is carried out in an environment under a reduced pressure of ≦500 mbara and the processing and/or handling comprises one or more process steps selected from the group consisting of filtration, milling, sieving, mixing, homogenization, granulation, compacting, packaging, drying, storage and transport in a transport container and other steps in apparatuses having mechanical internals.

Method of processing and handling solids and mixtures capable of deflagration, in particular of processing materials capable of deflagration in the chemical and pharmaceutical industry, wherein the processing and handling is carried out in an environment under a reduced pressure of ≦500 mbara and the processing and/or handling comprises one or more process steps selected from the group consisting of filtration, milling, sieving, mixing, homogenization, granulation, compacting, packaging, drying, storage and transport in a transport container and other steps in apparatuses having mechanical internals.

Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II) ##STR00001##
wherein X, X.sub.1, X.sub.2, X.sub.3, X.sub.4 and X.sub.5, R.sub.1 through R.sub.4 and R.sub.9 are as described.

Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II) ##STR00001##
wherein X, X.sub.1, X.sub.2, X.sub.3, X.sub.4 and X.sub.5, R.sub.1 through R.sub.4 and R.sub.9 are as described.

Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II)

##STR00001##

wherein X, X.sub.1, X.sub.2, X.sub.3, X.sub.4 and X.sub.5, R.sub.1 through R.sub.4 and R.sub.9 are as described.

Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II)

##STR00001##

wherein X, X.sub.1, X.sub.2, X.sub.3, X.sub.4 and X.sub.5, R.sub.1 through R.sub.4 and R.sub.9 are as described.